Skip to main content
OpenTrials
Completed

NCT Number: NCT01031082

Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children

The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 month–5 year

Sex eligibility

All sexes

Study type

Observational

Primary location

GSK Investigational Site

Soweto, Gauteng, 2013, South Africa

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Inclusion criteria

for all subjects:

  • Age: >= 3 months and < 5 years at the time of enrolment.
  • Signs, symptoms, and conditions:
  • One of the functional or general signs of otalgia,, conjunctivitis, fever and either
  • Paradise's criteria or
  • Spontaneous otorrhoea of less than 24 hours.
  • Subject will be included as a treatment failure case.
  • Written informed consent obtained from parent or guardian prior to study start.

Inclusion criteria

for HIV-positive subjects:

  • Documented HIV-positive status as given in subject's medical records. or
  • Subjects referred from paediatric HIV clinic.

Inclusion criteria

for HIV-negative subjects (including presumed negative children)

  • Children who have been tested HIV-negative.
  • Children whose mothers volunteer to have tested HIV-negative whilst pregnant with the index case and the child is free to any World Health Organization Grade II stigmata of HIV/acquired immunodeficiency syndrome.
  • Children who do not fulfil the World Health Organization staging for HIV infection / immunosuppression.

Exclusion criteria

  • Hospitalised during the diagnosis of acute otitis media or during treatment.
  • Otitis externa or otitis media with effusion.
  • Presence of a transtympanic aerator.
  • Systemic antibiotic treatment received for a disease other than acute otitis media in the 72 hours prior to enrolment.
  • Receiving antimicrobial prophylaxis for recurrent acute otitis media but excluding cotrimoxazole or isoniazid prophylaxis in HIV exposed children.
  • Provision of antibiotic by paediatrician/ENT specialist at the enrolment visit prior to the sampling of the middle ear fluid or spontaneous Otorrhoea.
  • Children on antibiotics for acute otitis media who are clinically improving.

Treatment and study plan

Middle ear fluid, nasopharyngeal aspirate and urine sample.

Procedure

Middle ear fluid, nasopharyngeal aspirate and urine sample collection.

Primary outcomes

  1. Occurrence of bacterial pathogens isolated from middle ear fluid samples in HIV-positive and HIV-negative subjects.

Secondary outcomes

  1. Occurrence of bacterial serotypes.

  2. Antimicrobial susceptibility of different bacteria isolated from middle ear fluid samples as assessed by standard microbiological techniques.

  3. Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.

  4. Occurrence of spontaneous otorrhoea.

  5. Occurrence of bacteria in acute otitis media cases with treatment failure and in new acute otitis media cases without treatment therapy.

  6. Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.

  7. Frequency of concurrent respiratory viral infection coinciding with the episode of acute otitis media.

  8. The comparison of above endpoints in HIV-positive and HIV-negative subjects.

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

Identification and Characterization of the Bacteria Causing Acute Otitis Media (AOM) Episodes in HIV-positive and HIV-negative Children in South Africa

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Dec 14, 2009
Registry last updated
May 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.